Durabond Joint Compound – USG Corporation

Product Description

Durabond joint compound is a setting-type drywall compound manufactured by USG Corporation, one of the largest wallboard and finishing materials producers in the United States. Unlike conventional air-drying joint compounds, Durabond products are chemically setting compounds, meaning they harden through a chemical reaction rather than simple evaporation of water. This characteristic made Durabond popular across residential, commercial, and industrial construction for applications where fast set times and high strength were required.

USG Corporation, headquartered in Chicago, Illinois, has been a dominant force in the gypsum products industry for well over a century. The company marketed Durabond under its established brand umbrella alongside other well-known products including SHEETROCK wallboard, IMPERIAL plaster, and a range of ceiling tile systems. Durabond joint compound was sold in powdered form, requiring workers to mix it with water on site before application.

The product was widely used by drywall finishers, plasterers, construction laborers, and other tradespeople involved in the taping, bedding, and finishing of interior wall and ceiling systems. Its use extended into industrial facilities, institutional buildings, and large-scale commercial projects where the demands of fast-paced construction schedules made setting compounds the preferred choice over slow-drying alternatives.

Asbestos Content

During portions of Durabond’s production history, USG Corporation incorporated asbestos into the formulation of this joint compound. Asbestos was added to joint compounds and related finishing products for several functional reasons: it improved workability, reduced cracking during setting, provided a degree of fire resistance, and enhanced the overall strength of the finished surface. These same physical properties that made asbestos attractive to manufacturers also made it extraordinarily hazardous to the workers who mixed, applied, and sanded these products.

The United States Gypsum Asbestos Personal Injury Settlement Trust — established as part of USG Corporation’s bankruptcy reorganization — specifically recognizes asbestos-containing products manufactured and distributed by USG Corporation, including Durabond joint compound. The existence of this trust confirms that USG acknowledged the presence of asbestos in certain products and accepted legal and financial responsibility for resulting personal injury claims.

Regulatory action by the Environmental Protection Agency (EPA) and the Occupational Safety and Health Administration (OSHA) during the 1970s led to the reformulation or elimination of asbestos in many joint compound products across the industry. However, workers who used Durabond during the years when asbestos-containing formulations were sold — and those who disturbed previously applied materials during renovation or demolition work — faced serious exposure risks.

How Workers Were Exposed

Occupational exposure to asbestos from Durabond joint compound occurred through several well-documented pathways, all connected to the ordinary tasks required to use the product.

Mixing: Durabond is a powder-based compound. Workers who opened bags and poured powder into mixing containers generated clouds of airborne dust. When asbestos was present in the formulation, this dust contained respirable asbestos fibers that could be inhaled with each breath taken during the mixing process. Workers who mixed compound repeatedly throughout a workday faced cumulative exposure over the course of entire careers.

Application and Taping: Applying joint compound to drywall seams, corners, and fastener heads brought workers into direct contact with the material. While wet compound poses a lower immediate inhalation risk, overspray, splatter, and incidental drying of applied product during work could release fibers into the breathing zone.

Sanding and Finishing: Sanding dried joint compound to achieve a smooth, paintable surface is one of the most hazardous steps in the drywall finishing process. OSHA and industrial hygiene research have consistently identified sanding as a primary source of asbestos fiber release from joint compound products. Workers using hand sanders, pole sanders, or power-sanding equipment on dried Durabond — when that compound contained asbestos — were exposed to high concentrations of airborne fibers.

Renovation and Demolition: Workers who disturbed existing joint compound applications during building renovation, repair, or demolition faced secondary exposure long after the original installation. Cutting, scraping, or grinding previously applied compound that contained asbestos released fibers just as effectively as the original application work.

Industrial workers generally, including those employed in facilities where Durabond was used for interior finishing and maintenance applications, are recognized among the trades and occupational categories potentially exposed. Construction laborers and general workers present in enclosed spaces during mixing, application, or sanding operations — even if not the primary applicators — could experience bystander exposure through the shared air environment of a worksite.

Asbestos fibers inhaled or ingested do not break down in the body. Over time, accumulated fiber burden can cause mesothelioma, asbestosis, lung cancer, and other serious diseases. These conditions often do not manifest until decades after the initial exposure, meaning workers who used Durabond joint compound during the product’s asbestos-containing production years may only now be receiving diagnoses.

The United States Gypsum Asbestos Personal Injury Settlement Trust was established to compensate individuals who suffered asbestos-related personal injuries as a result of exposure to asbestos-containing products manufactured or sold by USG Corporation and its subsidiaries. This trust is a Tier 1 resource, meaning it is an active, funded mechanism specifically designed to provide financial recovery to eligible claimants without requiring individual litigation against USG Corporation.

Eligible claimants include workers who can document occupational exposure to Durabond joint compound or other covered USG asbestos-containing products and who have been diagnosed with a qualifying asbestos-related disease. Diseases typically covered under asbestos personal injury trusts of this type include:

  • Mesothelioma (malignant, all forms)
  • Lung cancer (with documented asbestos exposure history)
  • Asbestosis (documented by pulmonary function testing and imaging)
  • Other asbestos-related conditions as defined by the trust’s claims evaluation criteria

Claims are filed directly with the United States Gypsum Asbestos Personal Injury Settlement Trust. The trust applies established criteria for evaluating exposure evidence, medical documentation, and disease severity. Claimants are typically required to demonstrate a sufficient connection between their occupational history and USG products, including Durabond joint compound, through work history affidavits, co-worker testimony, employment records, or other documented evidence.

Workers and surviving family members who believe they qualify for compensation through this trust should consult an attorney experienced in asbestos personal injury claims. Legal counsel can assist with gathering the exposure documentation and medical records required to support a claim, as well as identifying whether additional claims against other asbestos trusts or through civil litigation may also be appropriate given the individual’s full occupational history.

The establishment of the United States Gypsum Asbestos Personal Injury Settlement Trust reflects a legal and financial acknowledgment by USG Corporation that workers suffered harm from asbestos-containing products, including Durabond joint compound, produced and sold under the company’s name.